Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects
NCT02262520 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2015-08-10
Summary
The purpose of this study is to assess the effects of Apixaban on the Pharmacokinetics (PK) of multiple-dose Digoxin in healthy subjects.
Conditions
- N/A - Healthy Subjects
Interventions
- DRUG
-
Apixaban
- DRUG
-
Digoxin
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2006-03-31
- Completion
- 2006-03-31
More Related Trials
-
A Study of the Effect of Nemtabrutinib (MK-1026) on the Plasma Levels of Digoxin in Healthy Participants (MK-1026-012)
NCT06625827 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants
NCT05598281 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study Between Bosutinib And Dabigatran
NCT02102633 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
NCT06930872 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
NCT02227173 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
NCT00839683 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects
NCT02623296 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants
NCT04459585 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study
NCT01597310 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers
NCT01195324 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed
NCT01583036 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants
NCT06677957 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)
NCT01926509 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)
NCT07232589 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
NCT07065058 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin
NCT00860223 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants
NCT01873001 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)
NCT05137626 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
NCT03723395 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants
NCT06194214 ·Status: COMPLETED ·Phase: PHASE1
-
DDI Study With Multiple-dose LX4211 and Single Dose Digoxin
NCT02300350 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
NCT04902105 ·Status: COMPLETED ·Phase: PHASE1
-
A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS
NCT03827668 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)
NCT03909529 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants
NCT05994807 ·Status: COMPLETED ·Phase: PHASE1